DH gives green light to ISTCs
THREE MORE INDEPENDENT SECTOR TREATMENT CENTRE (ISTC) schemes have been approved by the Department of Health.
The new schemes are expected to provide over 1.5 million contracted procedures and outpatient consultations including general surgery, orthopaedics, ophthalmology and diagnostics.
Following a review of Phase 2 of the ISTC programme, two schemes in Greater Manchester and one in Hampshire and the Isle of Wight have been approved by the DH and HM Treasury and will go forward to financial close. This brings the current number of Phase 2 schemes to ten.
The DH also confirmed that independent sector provision will in future be procured locally rather than centrally.
Health Minister Ben Bradshaw said: “The independent sector is providing NHS patients with fast access to high-quality treatment and diagnostic services, offering greater choice, driving down waiting times and galvanising the NHS to raise its game.
“We are committed to independent sector involvement in the NHS where it meets local needs, offers value for money and benefits local patients. It is right that in future the local NHS will commission independent sector providers, to ensure faster procurement of services that reflect local needs.”
UK medtech companies at CMEF
EIGHT BRITISH MEDICAL TECHNOLOGY COMPANIES exhibited their products in the UK Pavilion at the China International Medical Equipment Fair (CMEF) in Shenzhen.
The exhibitors were Eschmann Equipment, Femcare- Nikomed Ltd, Medisavers, Pro-Lab Diagnostics, SLE Ltd, Swann-Morton Ltd, Water-Jel Europe LLP and the Industrial Design Consultancy.
The Association of British Healthcare Industries (ABHI) organised the UK Pavilion at CMEF with the support of UK Trade and Investment.
CMEF is the largest medical devices event in the Asia Pacific region. This year it occupied 100,000 square metres of exhibition space, with 13 national pavilions and over 2,000 exhibitors from 17 countries.
Mark Reed, General Manager of Pro-Lab Diagnostics – Europe, said: “With offices in Canada, the USA and the UK, we are currently seeking to expand our marketplace into China and have chosen CMEF to launch our products, having heard very positive remarks from colleagues within our industry who have done the same.”
CMEF is organised biannually by Reed Sinopharm Exhibitions. Ms. Hu Kun Ping, Vice President of RSE, said: “The diversity of national pavilions featured at this season’s event offers show participants myriad opportunities to trade and network with some of the world’s leading medical device companies.”
Siemens launches Women’s Health team
SIEMENS MEDICAL has launched an Ultrasound and Women’s Health division to provide a one-stop approach to breast imaging solutions in the UK.
The creation of the new dedicated team follows the Government’s announcement that screening for breast cancer will be extended, and reflects the growing importance of mammography and ultrasound in its diagnosis.
“The introduction of new applications and techniques such as elastography, silicon transducers and tomosynthesis has called for detailed and specialist advice in the marketplace,” said Andrew Pattison, Director of Diagnostic Ultrasound & Women’s Health at Siemens.
“Furthermore, with the Government’s commitment to extending screening services for women and greater awareness of symptoms by patients, this sector of the health service is facing increasing pressure. Our team of professionals will deliver a high level of consultancy, working with clinical teams at hospitals to explain how the latest technologies can deliver tangible benefits to improve patient outcomes.”
Breast cancer is the most common cancer in women in the UK, and early detection and diagnosis have been proven to increase survival rates.
Siemens has recently launched two new products that will fall into the Women’s Health team remit: the Acuson S2000 ultrasound system and the Mammomat Inspiration, a full-field digital mammography system.